<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pancreatic beta-cells exposed to high <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations display altered gene expression, function, survival and growth that may contribute to the slow deterioration of the functional beta-cell mass in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>These glucotoxic alterations may result from various types of stress imposed by the hyperglycaemic environment, including <z:mp ids='MP_0003674'>oxidative stress</z:mp>, endoplasmic reticulum stress, cytokine-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation of <z:mp ids='MP_0003674'>oxidative stress</z:mp>-response and integrated stress-response genes in cultured rat islets follows an asymmetric V-shaped profile parallel to that of beta-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, with a large increase at low <z:chebi fb="105" ids="17234">glucose</z:chebi> and a moderate increase at high vs. intermediate <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>These observations suggest that both types of stress could play a role in the alteration of the functional beta-cell mass under states of prolonged <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> and <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, beta-cell demise under glucotoxic conditions may also result from beta-cell <z:mp ids='MP_0005039'>hypoxia</z:mp> and, in vivo, from their exposure to inflammatory cytokines released locally by non-<z:chebi fb="32" ids="24621">endocrine</z:chebi> islet cells </plain></SENT>
<SENT sid="5" pm="."><plain>A better understanding of the relative contribution of each type of stress to beta-cell glucotoxicity and of their pathophysiological cause in vivo may lead to new therapeutic strategies to prevent the slow deterioration of the functional beta-cell mass in <z:chebi fb="105" ids="17234">glucose</z:chebi> intolerant and type 2 diabetic patients </plain></SENT>
</text></document>